$NUGN
Livento Group Inc Stock $nugn

$nugn Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000149315223009940 Filed on March 31, 2023

Income Statement

Concept	2022 Q4	2022
Revenue		$2.000M
YoY Change		0.0%
Cost Of Revenue		$2.071M
YoY Change
Gross Profit		-$105.1K
YoY Change
Gross Profit Margin		-5.25%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$482.3K
YoY Change
Operating Profit		-$587.4K
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net		$100.3K
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings		-$487.2K
YoY Change		126.71%
Net Earnings / Revenue		-24.36%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding	227.0M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$24.16K	$484.2K
Short-Term Investments
Other Short-Term Assets	$121.5K
YoY Change
Inventory	$0.00
Prepaid Expenses
Receivables	$489.9K
Other Receivables
Total Short-Term Assets	$635.5K	$484.2K
YoY Change	31.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$0.00
YoY Change
Goodwill	$0.00
YoY Change
Intangibles	$12.73M	$8.033M
YoY Change	58.43%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$22.68M	$19.96M
YoY Change	13.61%
TOTAL ASSETS
Total Short-Term Assets	$635.5K	$484.2K
Total Long-Term Assets	$22.68M	$19.96M
Total Assets	$23.32M	$20.45M
YoY Change	14.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$139.5K	$258.9K
YoY Change	-46.11%
Accrued Expenses	$62.55K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.248M	$258.9K
YoY Change	1154.58%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.248M	$258.9K
Total Long-Term Liabilities
Total Liabilities	$3.248M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings	-$12.45M	-$11.96M
YoY Change	4.07%
Common Stock	$22.70K	$76.59K
YoY Change	-70.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$20.07M	$20.19M
YoY Change
Total Liabilities & Shareholders Equity	$23.32M	$20.45M
YoY Change	14.03%

Cashflow Statement

Concept	2022 Q4	2022	2021 Q4
OPERATING ACTIVITIES
Net Income		-$487.2K
YoY Change		126.71%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities		$522.1K
YoY Change		-30.26%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$4.395M
YoY Change		-58.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		-$53.89K
YoY Change		-176.26%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$3.412M
YoY Change		-66.63%
NET CHANGE
Cash From Operating Activities		$522.1K
Cash From Investing Activities		-$4.395M
Cash From Financing Activities		$3.412M
Net Change In Cash		-$460.0K
YoY Change		-195.46%
FREE CASH FLOW
Cash From Operating Activities		$522.1K
Capital Expenditures		$0.00
Free Cash Flow		$522.1K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001593549
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001593549
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent		usd
CY2021Q4	NUGN	Co Investments CoInvestments		usd
CY2021Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2021	NUGN	Conversion Of Series C Preferred Shares To Common Shares With Specific Condition ConversionOfSeriesCPreferredSharesToCommonSharesWithSpecificCondition		usd
CY2021	NUGN	Stock Issued Value On Loan Settlement StockIssuedValueOnLoanSettlement		usd
CY2021	NUGN	Stock Issued Value Common Shares Settlement StockIssuedValueCommonSharesSettlement		usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2022	NUGN	Issuance Of Series C Preferred Shares To David Stybr And Their Cancelation IssuanceOfSeriesCPreferredSharesToDavidStybrAndTheirCancelation		usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2022	NUGN	Cancelation Of Common Shares By Former Director CancelationOfCommonSharesByFormerDirector		usd
CY2022	NUGN	Disposal Of Movies Project DisposalOfMoviesProject		usd
CY2021	NUGN	Disposal Of Movies Project DisposalOfMoviesProject		usd
CY2021	NUGN	Proceeds From Issuance Of Co Investment ProceedsFromIssuanceOfCoInvestment		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-56457
CY2022	dei	Entity Registrant Name EntityRegistrantName	LIVENTO GROUP, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3999052
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	17 State Street
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10004
CY2022	dei	City Area Code CityAreaCode	(980)
CY2022	dei	Local Phone Number LocalPhoneNumber	432-8241
CY2022	dei	Security12b Title Security12bTitle	Common stock, par value $0.0001
CY2022	dei	Trading Symbol TradingSymbol	NUGN
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	14301080	usd
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	227001268	shares
CY2022	dei	Auditor Firm AuditorFirmId	5968
CY2022	dei	Auditor Name AuditorName	OLAYINKA OYEBOLA & CO
CY2022	dei	Auditor Location AuditorLocation	Lagos, Nigeria
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24159	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	484183	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	489910	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	121460	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	635529	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	484183	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	9952880	usd
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	11929359	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12726847	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8033241	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	22679728	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	19962600	usd
CY2022Q4	us-gaap	Assets Assets	23315257	usd
CY2021Q4	us-gaap	Assets Assets	20446783	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	139530	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	258900	usd
CY2022Q4	NUGN	Co Investments CoInvestments	3046017	usd
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	62549	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3248096	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	258900	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	227001268	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	765895613	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	22700	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	76590	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	32493023	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	32074932	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12450797	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11963639	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20067160	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20187883	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23315257	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20446783	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1966202	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1840866	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	2071289	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1059589	usd
CY2022	us-gaap	Gross Profit GrossProfit	-105087	usd
	us-gaap	Gross Profit GrossProfit	781277	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	358231	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	334767	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	120750	usd
	us-gaap	Professional Fees ProfessionalFees	574009	usd
CY2022	NUGN	Rental Expense RentalExpense	3366	usd
	NUGN	Rental Expense RentalExpense	87100	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	482347	usd
	us-gaap	Operating Expenses OperatingExpenses	995876	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-587434	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-214598	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	100277	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-281	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-487158	usd
	us-gaap	Net Income Loss NetIncomeLoss	-214879	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	10175419	usd
CY2021	NUGN	New Preferred Shares Issued To Takeover Company By Former Management NewPreferredSharesIssuedToTakeoverCompanyByFormerManagement	0	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	10227343	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-214879	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20187883	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20187883	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20187883	usd
CY2022	NUGN	Stock Sales Of Series D Preferred Shares StockSalesOfSeriesDPreferredShares	366435	usd
CY2022	NUGN	Stock Cancelation Of Common Shares And Their Transformation To Series C Preferred Shares StockCancelationOfCommonSharesAndTheirTransformationToSeriesCPreferredShares	0	usd
CY2022	NUGN	Stock Sales Of Series C Preferred Shares StockSalesOfSeriesCPreferredShares	-0	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-487158	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20067160	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20067160	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-487158	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-214879	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1677410	usd
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	714589	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-178281	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	248900	usd
CY2022	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	489910	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	522061	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	748610	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	6371017	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3847200	usd
CY2022	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	-1976479	usd
CY2021	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	6646870	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4394538	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10494070	usd
CY2022	NUGN	Proceeds From Issuance Of Co Investment ProceedsFromIssuanceOfCoInvestment	3046017	usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	2234	usd
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	-192	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-53889	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	70664	usd
CY2022	NUGN	Proceeds From Issuance Of Additional Paidin Capital ProceedsFromIssuanceOfAdditionalPaidinCapital	418091	usd
CY2021	NUGN	Proceeds From Issuance Of Additional Paidin Capital ProceedsFromIssuanceOfAdditionalPaidinCapital	10156871	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3412452	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10227343	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-460024	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	481883	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	484183	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2300	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	24159	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	484183	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80C_eus-gaap--NatureOfOperations_z92tatQbwZ7e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 - <span id="xdx_820_zEPX4hfJMNj6">ORGANIZATION AND DESCRIPTION OF BUSINESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nugene International, Inc (formerly Bling Marketing) was incorporated in Nevada. On March 24, 2022, Livento Group LLC announced the acquisition of NUGN and confirmed a change in its business model, redirecting its focus to Livento’s three primary sectors: real estate finance & development, artificial intelligence, machine learning technology, and film and television production.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Livento Group LLC was acquired by Nugene International Inc, and the transaction was accounted for on a historical cost basis of Nugene International Inc i.e. (Ultimate Parent Basis). The Members capital of Livento Group LLC was recorded in the Additional paid in capital of Nugene International Inc.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Livento Group LLC was incorporated on <span id="xdx_90C_edei--EntityIncorporationDateOfIncorporation_c20220101__20221231_zcsnbLo5mJzf" title="Entity incorporation date">01/10/2020</span> in Delaware, USA. The business purpose of the company is management and business holding company for real estate and artificial intelligence services. Its focus in real estate is on residential development in Czech Republic and in artificial intelligence development of portfolio software used by asset managers to determine best mix of stocks from selected index.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change in Control</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nugene International Inc. issued its <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zFgzoXwHY81l" title="Number of shares issued">100</span> units of class A preference shares delivering 51% control and <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--ClassCPreferredSharesMember_zteZTO9HBFyd" title="Number of shares issued">5,000,000</span> units of Class C preference shares in acquisition of all the identifiable assets and Liabilities of Livento Group LLC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The company’s registered office is located in the State of Delaware, 19 Holly Cove Ln., City of Dover, Kent, 19901, Head office on 17 State Street, Suite 4000, New York, NY, 10004.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s founder and director is David Stybr</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2020-01-10
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zt0nTaLtUTff" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_860_zp78HmrVVnY4">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated useful lives of property and equipment. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zER4UJAPKKqd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_865_zlOhu1lmSPfg">Concentrations of Credit Risk</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. The Company continually monitors its banking relationships and consequently has not experienced any losses in its accounts. Management believes the Company is not exposed to any significant credit risk on cash.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	484183	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24159	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	NUGN	Asset Acquisition Percentage Of Shares Transferred AssetAcquisitionPercentageOfSharesTransferred	1	pure
CY2022Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	7171659	usd
CY2022	us-gaap	Revenues Revenues	2000000	usd
CY2021	us-gaap	Revenues Revenues	2000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10086617	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5032230	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	714589	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1677410	usd

Files In Submission

Name	View Source	Status
0001493152-23-009940-index-headers.html	Edgar Link	pending
0001493152-23-009940-index.html	Edgar Link	pending
0001493152-23-009940.txt	Edgar Link	pending
0001493152-23-009940-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
fin-2_001.jpg	Edgar Link	pending
fin-2_002.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-k_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nugn-20221231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
nugn-20221231_cal.xml	Edgar Link	unprocessable
nugn-20221231_def.xml	Edgar Link	unprocessable
nugn-20221231_lab.xml	Edgar Link	unprocessable
nugn-20221231_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NUGN
Livento Group Inc Stock $nugn

2022 Q4 Form 10-K Financial Statement

#000149315223009940 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NUGN Livento Group Inc Stock $nugn

2022 Q4 Form 10-K Financial Statement

#000149315223009940 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NUGN
Livento Group Inc Stock $nugn